Evidence map›Paper›PMID 25392487›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

A lipid gate for the peripheral control of pain.

Daniele Piomelli, Andrea G Hohmann, Virginia Seybold, Bruce D Hammock

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Efficacy ofNutrients · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Cannabinoid CBCannabis and cannabinoid research · 2021
    Article
  12. The Role of PPAR Alpha in the Modulation of Innate Immunity.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. CBPharmacology, biochemistry, and behavior · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Daniele PiomelliDepartments of Anatomy and Neurobiology, Pharmacology and Biological Chemistry, University of California, Irvine, California 92697-1275, Department of Drug Discovery and Development, Istituto Italiano di Tecnologia, Genova, Italy 16163, piomelli@uci.edu.
Andrea G HohmannDepartment of Psychological and Brain Sciences and Program in Neuroscience, and Gill Center for Biomolecular Science, Indiana University, Bloomington, Indiana 47405.ORCID http://orcid.org/0000-0003-0941-6435
Virginia SeyboldDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, and.
Bruce D HammockDepartment of Entomology, University of California, Davies, California 95616-8584.
Indiana University Bloomington · USUniversity of California, Davis · USUniversity of California, Irvine · USUniversity of Minnesota · US

Funding

Project 3 - In vivo pharmacology of cannabinoid receptor probesP01DA009158 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI Alexandros Makriyannis · 1994 to 2026
$26.0M
Characterization of Anandamide Transport in BrainR01DA012413 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI PIOMELLI, DANIELE · 1998 to 2016
$4.7M
Optimization and preclinical development of FAAH inhibitors for smoking cessationDP1DA031387 · NIDA · UNIVERSITY OF CALIFORNIA-IRVINE · PI PIOMELLI, DANIELE · 2010 to 2014
$3.7M
Protein-protein interaction inhibitors as novel analgesicsR21DA037673 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI HOHMANN, ANDREA GRACE · 2013 to 2014
$429k
NIDA NIH HHS DP1 DA031387NIDA NIH HHS P01 DA009158NIDA NIH HHS R01 DA012413NIDA NIH HHS R21 DA037673
6 · The paper itself

Abstract

Cells in injured and inflamed tissues produce a number of proalgesic lipid-derived mediators, which excite nociceptive neurons by activating selective G-protein-coupled receptors or ligand-gated ion channels. Recent work has shown that these proalgesic factors are counteracted by a distinct group of lipid molecules that lower nociceptor excitability and attenuate nociception in peripheral tissues. Analgesic lipid mediators include endogenous agonists of cannabinoid receptors (endocannabinoids), lipid-amide agonists of peroxisome proliferator-activated receptor-α, and products of oxidative metabolism of polyunsaturated fatty acids via cytochrome P450 and other enzyme pathways. Evidence indicates that these lipid messengers are produced and act at different stages of inflammation and the response to tissue injury, and may be part of a peripheral gating mechanism that regulates the access of nociceptive information to the spinal cord and the brain. Growing knowledge about this peripheral control system may be used to discover safer medicines for pain.

Indexed as

AnimalsCannabinoid Receptor AgonistsEndocannabinoidsHumansHyperalgesiaInflammationPainPPAR alphaReceptors, CannabinoidCannabinoid Receptor AgonistsEndocannabinoidsPPAR alphaReceptors, Cannabinoid

Identifiers

PMID25392487
PMCPMC4228127
OpenAlexW2100773682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.